These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17646959)

  • 1. [Papillary renal cell carcinoma and tumor biology. A multicenter project with "tissue microarray" (TMA)].
    Herrmann E; Wülfing C; Hartmann A
    Urologe A; 2007 Sep; 46(9):1175-6. PubMed ID: 17646959
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene expression profiling of renal cell carcinoma and clinical implications.
    Rogers CG; Tan MH; Teh BT
    Urology; 2005 Feb; 65(2):231-7. PubMed ID: 15708028
    [No Abstract]   [Full Text] [Related]  

  • 3. CD1d expression in renal cell carcinoma is associated with higher relapse rates, poorer cancer-specific and overall survival.
    Chong TW; Goh FY; Sim MY; Huang HH; Thike AA; Lim WK; Teh BT; Tan PH
    J Clin Pathol; 2015 Mar; 68(3):200-5. PubMed ID: 25477528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of tissue microarrays for the diagnosis, prognosis and therapeutic decision making in renal cell carcinoma].
    Merseburger AS; Hennenlotter J; Schilling D; Sievert KD; Küfer R; Kuczyk MA
    Urologe A; 2006 Mar; 45(3):323-4, 326-7. PubMed ID: 16465523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases.
    Wuttig D; Zastrow S; Füssel S; Toma MI; Meinhardt M; Kalman K; Junker K; Sanjmyatav J; Boll K; Hackermüller J; Rolle A; Grimm MO; Wirth MP
    Int J Cancer; 2012 Sep; 131(5):E693-704. PubMed ID: 22213152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 1 and 2 papillary renal cancers are genetically distinct.
    Balakrishnan VS
    Lancet Oncol; 2015 Dec; 16(16):e594. PubMed ID: 26596671
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic factors in renal cell carcinoma.
    Ljungberg B
    Urologe A; 2004 Sep; 43 Suppl 3():S119-20. PubMed ID: 15179550
    [No Abstract]   [Full Text] [Related]  

  • 8. [Transcriptome analyses in renal cell carcinoma. Combination of laser microdissection and microarrays].
    Buchner A; Castro M; Hennig A; Popp T; Assmann G; Hofstetter A; Stief C; Zimmermann W
    Urologe A; 2007 Sep; 46(9):1170-5. PubMed ID: 17646957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
    Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P
    BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of
    Yang CA; Huang HY; Yen JC; Chang JG
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29843367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of CD31 (PECAM-1) expression using tissue microarray in patients with renal cell carcinoma.
    Sandlund J; Hedberg Y; Bergh A; Grankvist K; Ljungberg B; Rasmuson T
    Tumour Biol; 2007; 28(3):158-64. PubMed ID: 17510564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40 expression in renal cell carcinoma is associated with tumor apoptosis, CD8(+) T cell frequency and patient survival.
    Weiss JM; Gregory Alvord W; Quiñones OA; Stauffer JK; Wiltrout RH
    Hum Immunol; 2014 Jul; 75(7):614-20. PubMed ID: 24801648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma.
    Yang M; Hlady RA; Zhou D; Ho TH; Robertson KD
    Cancer Med; 2019 Sep; 8(12):5760-5768. PubMed ID: 31361072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of PI3K is associated with reduced survival in renal cell carcinoma.
    Merseburger AS; Hennenlotter J; Kuehs U; Simon P; Kruck S; Koch E; Stenzl A; Kuczyk MA
    Urol Int; 2008; 80(4):372-7. PubMed ID: 18587247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal cell carcinoma associated proteins. Isolation, cloning and immunogenicity evaluation].
    Haferkamp A; Hohenfellner M; Hautmann R; Zöller M
    Urologe A; 2007 Sep; 46(9):1292-8. PubMed ID: 17628779
    [No Abstract]   [Full Text] [Related]  

  • 16. Significance of amyloid A immunoexpression in the prognosis of renal cell carcinoma.
    Oz Atalay F; Aytac Vuruskan B; Vuruskan H
    APMIS; 2016 Apr; 124(4):257-62. PubMed ID: 26750935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
    Kosari F; Parker AS; Kube DM; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Vasmatzis G
    Clin Cancer Res; 2005 Jul; 11(14):5128-39. PubMed ID: 16033827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary renal cell carcinoma: a clinicopathological and whole-genome exon sequencing study.
    Liu K; Ren Y; Pang L; Qi Y; Jia W; Tao L; Hu Z; Zhao J; Zhang H; Li L; Yue H; Han J; Liang W; Hu J; Zou H; Yuan X; Li F
    Int J Clin Exp Pathol; 2015; 8(7):8311-35. PubMed ID: 26339402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLAGL1 (ZAC1/LOT1) Expression in Clear Cell Renal Cell Carcinoma: Correlations with Disease Progression and Unfavorable Prognosis.
    Godlewski J; Krazinski BE; Kowalczyk AE; Kiewisz J; Kiezun J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Maslowski Z; Kmiec Z
    Anticancer Res; 2016 Feb; 36(2):617-24. PubMed ID: 26851016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of gene expression analysis of renal cell carcinoma.
    Leppert JT; Pantuck AJ
    Expert Rev Anticancer Ther; 2006 Feb; 6(2):293-9. PubMed ID: 16445381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.